News
1h
East Idaho News on MSNIdaho student goes off-script during grad speech to address district poster controversyOthers have created a crisis out of an unpolitical poster that supports the basic sentiment ‘Everyone is Welcome’ in this ...
BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing cancer therapies, today announces that it will have a poster ...
OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced that three of its research abstracts have been accepted for poster ...
MAIA Biotechnology, Inc. , a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that an abstract about the efficacy data from the Phase ...
From scholarly lectures to TED-style talks, from academic posters to interactive workshops ... and societal spheres. Here is a small sample of their recent work, showcasing the breadth and depth of ...
today announced its abstract has been selected for a poster presentation at the 2025 European Hematology Association Annual Meeting (EHA) being held June 12-15 in Milan, Italy. The abstract ...
About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the presentation of six posters, including one oral ...
Dynavax has the optimal Board with uniquely qualified directors to drive the Company's value creation potential. Deep Track's flawed plan puts future stockholder value at risk and the fund ...
You can use a combination of recruiting/development, the transfer portal and NIL to build a roster. How should Miami do it?
2025 Presentation Time: 11:00 AM – 1:00 PM PT Location: Room 3009/3011 (West Building, Level 3), Moscone Center Session (D106): Late-Breaking Advances in Pulmonary Vascular Disease: Basic Science, ...
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results